Blood Disorders Resource Center

Anemia Prevalence among Mexican Patients with CKD

Kidney Week 2020 Patients with chronic kidney disease (CKD) often experience anemia, a condition commonly associated with physical disability, decreased cognitive function, and poor quality...

Comorbidities in Patients with CKD Across KDIGO Stages

Kidney Week 2020 Chronic kidney disease (CKD) is a leading public health problem worldwide. At present, only estimates based on records of patients with advanced...
Dr. Tony Lin Summarizes Venclexta Data Presented at ASH

Dr. Tony Lin Summarizes Venclexta Data Presented at ASH

The all-virtual 62nd ASH Annual Meeting & Exposition highlighted some of the newest data about Venclexta. DocWire News interviewed Tony Lin, Pharm.D., a Senior...
Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

LUMMICAR-2: CT053 BCMA CAR T Is Active in Refractory Myeloma, But Toxicity Persists

The novel chimeric antigen receptor (CAR) T cell therapy, CT053, achieved a 100% overall response rate (ORR) for the treatment of relapsed/refractory multiple myeloma...

Oral Iron Therapy in Pediatric CKD Patients

Kidney Week 2020 Patients with chronic kidney disease (CKD) commonly develop anemia. Current guidelines recommend oral iron therapy as first-line treatment for anemia. According to...

Prevalence of Anemia in Patients with Non-Dialysis Dependent CKD

Kidney Week 2020 Anemia in patients with chronic kidney disease (CKD) is associated with erythropoietin deficiency and resistance, and a heightened inflammatory state. Treatment with...

Roxadustat Efficacious and Safe in Non-Dialysis-Dependent CKD Patients with Anemia

Kidney Week 2020 Researchers in Japan conducted study of roxadustat, an orally active hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anemia in chronic...

Curated Journal Reading List